Federal contract award

75A50123C00029

RESEARCH AND DEVELOPMENT- AOI #19 FOR THE DEVELOPMENT OF A BREAKTHROUGH NANOFLUID BREATHING AID FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS.

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	BARDA - ASPR / DAAPPO / BARDA DCMA
NAICS	541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSC	AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Parent award / vehicle	Not reported
Set-aside	NO SET ASIDE USED.
Pricing type	FIRM FIXED PRICE
Obligations	$372.8K
Current contract value	$372.8K
Potential contract value / ceiling	$372.8K
Start date	Jun 29, 2023
Current end date	Oct 7, 2025
Potential end date	Oct 7, 2025
Latest award activity	Oct 8, 2025
Source loaded	Sep 26, 2026

Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Oct 8, 2025	P00005	$-372.8K	RESEARCH AND DEVELOPMENT- AOI #19
Jun 10, 2025	P00004	$0	RESEARCH AND DEVELOPMENT- AOI #19 FOR THE DEVELOPMENT OF A BREAKTHROUGH NANOFLUID BREATHING AID FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS.
Oct 29, 2024	P00003	$0	RESEARCH AND DEVELOPMENT- AOI #19 FOR THE DEVELOPMENT OF A BREAKTHROUGH NANOFLUID BREATHING AID FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS.
Feb 29, 2024	P00002	$0	RESEARCH AND DEVELOPMENT- AOI #19 FOR THE DEVELOPMENT OF A BREAKTHROUGH NANOFLUID BREATHING AID FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS.
Nov 6, 2023	P00001	$0	RESEARCH AND DEVELOPMENT- AOI #19 FOR THE DEVELOPMENT OF A BREAKTHROUGH NANOFLUID BREATHING AID FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS.
Jun 29, 2023	0	$745.5K	RESEARCH AND DEVELOPMENT- AOI #19 FOR THE DEVELOPMENT OF A BREAKTHROUGH NANOFLUID BREATHING AID FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS.